Last reviewed · How we verify

P. vivax infected mosquito bites

Socrates Herrera Valencia · Phase 1 active Biologic

P. vivax infected mosquito bites is a Biologic drug developed by Socrates Herrera Valencia. It is currently in Phase 1 development.

At a glance

Generic nameP. vivax infected mosquito bites
SponsorSocrates Herrera Valencia
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about P. vivax infected mosquito bites

What is P. vivax infected mosquito bites?

P. vivax infected mosquito bites is a Biologic drug developed by Socrates Herrera Valencia.

Who makes P. vivax infected mosquito bites?

P. vivax infected mosquito bites is developed by Socrates Herrera Valencia (see full Socrates Herrera Valencia pipeline at /company/socrates-herrera-valencia).

What development phase is P. vivax infected mosquito bites in?

P. vivax infected mosquito bites is in Phase 1.

Related